1. Home
  2. MCS vs PEPG Comparison

MCS vs PEPG Comparison

Compare MCS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$17.49

Market Cap

479.7M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$6.58

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCS
PEPG
Founded
1935
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
440.0M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
MCS
PEPG
Price
$17.49
$6.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$23.75
$11.67
AVG Volume (30 Days)
130.3K
597.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.86%
N/A
EPS Growth
N/A
13.64
EPS
0.77
N/A
Revenue
$758,458,000.00
N/A
Revenue This Year
$11.78
N/A
Revenue Next Year
$3.09
N/A
P/E Ratio
$22.40
N/A
Revenue Growth
3.11
N/A
52 Week Low
$12.85
$0.89
52 Week High
$18.80
$7.80

Technical Indicators

Market Signals
Indicator
MCS
PEPG
Relative Strength Index (RSI) 71.28 59.20
Support Level $16.66 $4.36
Resistance Level $18.53 $6.81
Average True Range (ATR) 0.68 0.60
MACD 0.14 0.04
Stochastic Oscillator 84.38 66.89

Price Performance

Historical Comparison
MCS
PEPG

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: